4[3]American Diadetes Association.Screening for type 2 diabetes[J].Diabetes Care,2004,27:S11-14.
5[4]Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Report of expert committee the diagnosis and classification of diabetes mellitus[J].Diabetes Care,2003,26:S5-20.
6[6]De Luca L,De Persio G,Minati M,et al.Effects of abciximab and preprocedural glycemic control in diabetic patients undergoing elective coronary stenting[J].Am Heart J.2005,149:1135.
7[7]Solymoss BC,Bourassa MG,Lesperance S,et al.Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease[J].Coron Artery Dis,2003,14:207-212.
8[9]Komowski R,Fuchs S.Optimization of glycemic control and restenosis prevention in diabetic patients undergoing percutaneous coronary interventions[J].J Am Coll Cardiol,2004,7,43:15-17.
9[10]Capes SD,Hunt D,Malmberg K,et al.Stress hyperglycaemia and increased risk of death after myocardial infarction with and without diabetes,a systematic overview[J].Lancat,2000,355:773-778.
10Cambien F , Alherc GF , Herberth B , et al. Familial resemblance of plasma angiotensin-eonverting level in the Nancy . Am J Hum Genet , 1998 ; 43 :774.
